IQ Advertising Consultants

Current News

JUUL Settlement Reached To Resolve Teen Vaping LawsuitsDec, 07 2022
JUUL has announced it has reached a global settlement to resolve teen vaping lawsuits filed in federal courts nationwide. The post JUUL Settlement Reached To Resolve Teen Vaping Lawsuits appeared first on AboutLawsuits.com.
MDL Judge Dismisses Zantac Litigation, After Excluding Expert Testimony on Cancer RiskDec, 07 2022
A judge has ordered all federal Zantac lawsuits dismissed after questioning the science behind claims that the recalled heartburn drug is linked to an increased risk of cancer. The post MDL Judge Dismisses Zantac Litigation, After Excluding Expert Testimony on Cancer Risk appeared first on AboutLawsuits.com.
Roundup May Increase Risk Antibiotic Resistance to Bacterial Infection That Kills Thousands of Americans Every Year: StudyDec, 07 2022
The findings of a new study warn that Roundup exposure could lead to the development of antibiotic resistance in dangerous, infection-causing microorganisms. The post Roundup May Increase Risk Antibiotic Resistance to Bacterial Infection That Kills Thousands of Americans Every Year: Study appeared first on AboutLawsuits.com.
Study Shows Car Accidents Involving Prescription Opioid Drugs Have Dropped Significantly In Recent YearsDec, 07 2022
CDC guidelines to prevent overprescribing of opioids appears to have helped drive down opioid-related car accident rates in recent years, according to a new study. The post Study Shows Car Accidents Involving Prescription Opioid Drugs Have Dropped Significantly In Recent Years appeared first on AboutLawsuits.com.
Hair Relaxer Uterine Cancer Risks Linked to Endocrine Disruptors and Phthalate ExposureDec, 06 2022
Chemicals used in hair straightener products have been linked to potential reproductive problems for years, according to hair relaxer uterine cancer lawsuits. The post Hair Relaxer Uterine Cancer Risks Linked to Endocrine Disruptors and Phthalate Exposure appeared first on AboutLawsuits.com.
Parties Agree on Bellwether Selection Plan for Gardasil Vaccine LitigationDec, 06 2022
The parties have agreed to a schedule for the selection of early test cases in Gardasil vaccine litigation. The post Parties Agree on Bellwether Selection Plan for Gardasil Vaccine Litigation appeared first on AboutLawsuits.com.
New Clinical Data Shows Abiomed Impella RP Heart Pump is Safe, Despite Concerns Over Patient Deaths: FDADec, 06 2022
The FDA has released clinical trial data on Abiomed Impella RP Heart Pump Systems, declaring the device safe, but updated its warning label to recommend it only be used on certain patients. The post New Clinical Data Shows Abiomed Impella RP Heart Pump is Safe, Despite Concerns Over Patient Deaths: FDA appeared first on AboutLawsuits.com.
Cartiva Toe Implant Results in More Post-Operative Pain, But May Improve Outcomes: StudyDec, 06 2022
A new study links Cartiva toe implant surgery to an increased risk of post-operative pain when compared to other ways to address big toe arthritis. The post Cartiva Toe Implant Results in More Post-Operative Pain, But May Improve Outcomes: Study appeared first on AboutLawsuits.com.
High-Dose Marijuana Exposure Among Teens Linked to Neurological Problems: StudyDec, 06 2022
A new study finds that teens who are exposed to high doses of marijuana engage in more risky behavior and suffer cognitive impairments later in life. The post High-Dose Marijuana Exposure Among Teens Linked to Neurological Problems: Study appeared first on AboutLawsuits.com.
Doctors’ Jargon Often Confuses Patients, Leading to Worse Health Outcomes: StudyDec, 05 2022
A new study warns that doctors often use medical jargon which confuses patients, and could lead to poor medical outcomes. The post Doctors’ Jargon Often Confuses Patients, Leading to Worse Health Outcomes: Study appeared first on AboutLawsuits.com.

Philips Respironics Recalls Certain BiPAP Machines for Plastic Issue that May Expose Patients to Certain Chemicals of ConcernDec, 06 2022
Certain Philips Respironics BiPAP machines are recalled due to a plastic issue that may expose patients to certain chemicals of concern.
Update on Endologix AFX Endovascular AAA Graft Systems and Risk of Type III Endoleak: FDA Safety CommunicationDec, 06 2022
New labeling for AFX2 Endovascular AAA System (AFX2) includes information to better inform patients and health care providers of the risk of Type III endoleaks
2022 Safety CommunicationsDec, 06 2022
Listing of Medical Device 2022 Safety Communications
Update on Risk of Type III Endoleaks with Use of Endologix AFX Endovascular AAA Graft Systems – FDA Safety CommunicationDec, 06 2022
Do not routinely use AFX2 endovascular grafts for patients with abdominal aortic aneurysms.
Certain Philips Respironics BiPAP Machines Recalled Due to a Plastic Issue: FDA Safety CommunicationDec, 06 2022
Philips Respironics recalled certain BiPAP machines due to a plastic issue that may release certain chemicals of concern and cause device failure.
UPDATE: Impella RP System Post-Approval Study Results and Updated Labeling - Letter to Health Care ProvidersDec, 05 2022
The FDA is issuing this update to inform the health care community of the final PAS results and updated labeling for the Impella RP System by Abiomed.
2022 Letters to Health Care ProvidersDec, 05 2022
The FDA posts letters to health care providers about the safe use of medical devices.
Getinge Maquet/Datascope Intra-Aortic Balloon Pump (IABP) Shortage - Letter to Health Care ProvidersDec, 02 2022
The FDA is alerting health care facilities and providers of a shortage of Getinge Maquet/Datascope Intra-Aortic Balloon Pump (IABP) devices, including limited supplies of IAB catheters, new Cardiosave IABPs, and Cardiosave IABP parts.
Getinge’s Maquet/Datascope IABP Devices: Update on Device Failure – Letter to Health Care ProvidersDec, 02 2022
The FDA is updating information about Getinge’s Maquet/Datascope IABP devices including information about three voluntary recalls.
Exela Pharma Sciences, LLC Expands Voluntary Nationwide Recall of Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq/50 mL Vial, 20-Count Carton due to Vial Breakage UPDATED November 28, 2022Nov, 29 2022
Lenoir, North Carolina. Exela Pharma Sciences, LLC, (Exela) is expanding their recall, adding fourteen (14) lots to the ongoing voluntary recall of forty-nine (49) lots of Sodium Bicarbonate Injection, USP, 8.4%, 50 mEq/50 mL vial, 20-count carton. A total of 63 lots are now being recalled to the c
2022 Medical Device RecallsNov, 23 2022
List of Medical Device recalls in 2022.
Baxter Hillrom Recalls WatchCare Incontinence Management System (IMS) for Risk of RF Interference with Nearby Medical EquipmentNov, 23 2022
The WatchCare IMS includes hospital beds and disposable incontinence pads. Radiofrequency emissions from the system may interfere with other medical devices.
Prolia (denosumab) by Amgen: Drug Safety Communication - FDA Investigating Risk of Severe Hypocalcemia in Patients on DialysisNov, 22 2022
FDA is investigating the risk of severe hypocalcemia with serious outcomes, including hospitalization and death, in patients with advanced kidney disease on dialysis treated with the osteoporosis medicine Prolia (denosumab).
UPDATE: Certain Philips Respironics Ventilators, BiPAP Machines, and CPAP Machines Recalled Due to Potential Health Risks: FDA Safety CommunicationNov, 22 2022
This update provides additional information on the recall and recommendations for people who use repaired and replaced devices.
FAQs on Philips Respironics Ventilator, BiPAP Machine, and CPAP Machine RecallsNov, 22 2022
Find answers to frequently asked questions on Philips Respironics ventilators, BiPAP, and CPAP machines recall
At-Home COVID-19 Antigen Tests-Take Steps to Reduce Your Risk of False Negative Results: FDA Safety CommunicationNov, 17 2022
The FDA recommends repeat testing following a negative result to reduce the risk that a COVID-19 infection could be missed, whether or not you have symptoms.
Insulet Recalls Omnipod DASH Insulin Management System's Personal Diabetes Manager (PDM) for Risk of Battery Swelling, Leakage, or Extreme OverheatingNov, 16 2022
Omnipod DASH Insulin Management System’s Personal Diabetes Manager may have battery issues including swelling, fluid leakage, and extreme overheating.
Insulet Issues a Nationwide Voluntary Medical Device Correction for the Omnipod® 5 ControllerNov, 15 2022
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), today announced a Medical Device Correction for the Omnipod® 5 Automated Insulin Delivery System because of an issue with the Omnipod 5 Controller charging port and cable. This does not impact the Omnipod 5 Pod, the Omnipod® DASH Insulin M
Pulse Oximeter Accuracy and Limitations: FDA Safety CommunicationNov, 07 2022
The FDA is informing patients and health care providers that pulse oximeters have limitations and a risk of inaccuracy that must be considered.
Exactitud y limitaciones de los pulsioxímetros: Comunicado de seguridad de la FDANov, 07 2022
La FDA está informando a los pacientes y proveedores de atención médica de que los oxímetros de pulso tienen limitaciones y un riesgo de inexactitud que debe tenerse en cuenta.